Barclays PLC Purchases 33,432 Shares of CorVel Co. (NASDAQ:CRVL)

Barclays PLC boosted its stake in shares of CorVel Co. (NASDAQ:CRVL - Free Report) by 209.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 49,409 shares of the business services provider's stock after purchasing an additional 33,432 shares during the period. Barclays PLC owned about 0.10% of CorVel worth $5,497,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CRVL. Fifth Third Bancorp increased its stake in shares of CorVel by 45.9% in the fourth quarter. Fifth Third Bancorp now owns 321 shares of the business services provider's stock worth $36,000 after acquiring an additional 101 shares during the last quarter. Franklin Resources Inc. grew its stake in CorVel by 9.9% in the third quarter. Franklin Resources Inc. now owns 1,917 shares of the business services provider's stock valued at $614,000 after purchasing an additional 173 shares in the last quarter. Bessemer Group Inc. increased its position in CorVel by 6,350.0% in the 4th quarter. Bessemer Group Inc. now owns 258 shares of the business services provider's stock worth $29,000 after purchasing an additional 254 shares during the last quarter. US Bancorp DE raised its stake in shares of CorVel by 225.4% during the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider's stock worth $43,000 after purchasing an additional 266 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of CorVel by 175.2% during the 4th quarter. GAMMA Investing LLC now owns 432 shares of the business services provider's stock valued at $48,000 after buying an additional 275 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company's stock.

Insider Buying and Selling

In other news, Director Jeffrey J. Michael sold 16,523 shares of the business's stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $116.99, for a total value of $1,933,025.77. Following the completion of the sale, the director now directly owns 551,787 shares in the company, valued at approximately $64,553,561.13. The trade was a 2.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Brandon O'brien sold 1,523 shares of the company's stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total transaction of $182,089.88. Following the sale, the chief financial officer now directly owns 17,142 shares of the company's stock, valued at approximately $2,049,497.52. This represents a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 48,723 shares of company stock worth $5,757,140. 47.57% of the stock is currently owned by insiders.

CorVel Stock Down 0.7 %

Shares of CRVL traded down $0.75 during mid-day trading on Tuesday, hitting $109.00. 212,201 shares of the company's stock were exchanged, compared to its average volume of 118,271. The stock has a market cap of $5.60 billion, a price-to-earnings ratio of 64.12 and a beta of 0.94. The firm has a fifty day moving average of $110.39 and a two-hundred day moving average of $115.76. CorVel Co. has a twelve month low of $76.53 and a twelve month high of $128.61.

CorVel (NASDAQ:CRVL - Get Free Report) last posted its earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded CorVel from a "hold" rating to a "buy" rating in a report on Friday, April 18th.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.